Catalyst Wire Dossier Catalyst Wire Dossier

Epratuzumab

epratuzumab · UCB Pharma
Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for Epratuzumab, covering 2011-09-12 to 2018-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus [Phase 3]

See pricing